Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy
Article first published online: 29 JAN 2013
© 2013 BJU International
How to Cite
Todenhöfer, T., Hennenlotter, J., Leidenberger, P., Wald, A., Hohneder, A., Kühs, U., Mischinger, J., Aufderklamm, S., Gakis, G., Blumenstock, G., Stenzl, A. and Schwentner, C. (2013), Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy. BJU International. doi: 10.1111/j.1464-410X.2012.11759.x
- Article first published online: 29 JAN 2013
Options for accessing this content:
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!